April 17th, 2025 |
Aaron Bloomer |
Evp, Chief Financial Officer |
Payment In Kind Exercise
|
59.77K |
$479.54K |
38.72K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Restricted Stock Units |
Exercise/Conversion
|
12904 |
$0.00 |
$- |
Common Stock |
Exercise/Conversion
|
12904 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
5717 |
$44.25 |
$252.98K |
Common Stock |
Exercise/Conversion
|
11556 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
5120 |
$44.25 |
$226.56K |
Restricted Stock Units |
Exercise/Conversion
|
11566 |
$0.00 |
$- |
|
March 10th, 2025 |
Kevin Conroy |
Director, Officer: President And CEO |
Payment In Kind Exercise
|
182.38K |
$5.29M |
1.20M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
66723 |
$22.38 |
$1.49M |
Common Stock |
Payment In Kind
|
48929 |
$47.06 |
$2.30M |
Stock Options (Right to Buy) |
Exercise/Conversion
|
66723 |
$22.38 |
$1.49M |
|
March 4th, 2025 |
James Herriott |
Svp, General Counsel & Sec |
Payment In Kind Exercise
|
10.54K |
$95.93K |
16.34K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
2375 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
1117 |
$47.82 |
$53.41K |
Common Stock |
Exercise/Conversion
|
1890 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
889 |
$47.82 |
$42.51K |
Restricted Stock Units |
Exercise/Conversion
|
2375 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
1890 |
$0.00 |
$- |
|
March 4th, 2025 |
Kevin Conroy |
Director, Officer: President And CEO |
Payment In Kind Exercise
|
99.57K |
$906.05K |
1.15M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
22167 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
10419 |
$47.82 |
$498.24K |
Common Stock |
Exercise/Conversion
|
18143 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
8528 |
$47.82 |
$407.81K |
Restricted Stock Units |
Exercise/Conversion
|
22167 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
18143 |
$0.00 |
$- |
|
March 4th, 2025 |
Brian Baranick |
Evp, Gm, Precision Oncology |
Payment In Kind Exercise
|
24.26K |
$234.94K |
25.11K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
4948 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
2513 |
$47.82 |
$120.17K |
Common Stock |
Exercise/Conversion
|
4725 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
2400 |
$47.82 |
$114.77K |
Restricted Stock Units |
Exercise/Conversion
|
4948 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
4725 |
$0.00 |
$- |
|
March 4th, 2025 |
Jacob Orville |
Evp, Gm, Screening |
Payment In Kind Exercise
|
23.89K |
$217.44K |
27.73K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
4948 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
2326 |
$47.82 |
$111.23K |
Common Stock |
Exercise/Conversion
|
4725 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
2221 |
$47.82 |
$106.21K |
Restricted Stock Units |
Exercise/Conversion
|
4948 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
4725 |
$0.00 |
$- |
|
March 4th, 2025 |
Sarah Condella |
Evp, Human Resources |
Payment In Kind Gift Exercise
|
20.17K |
$173.97K |
84.40K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
3958 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
1861 |
$47.82 |
$88.99K |
Common Stock |
Exercise/Conversion
|
3780 |
$0.00 |
$- |
Common Stock |
Gift
|
1055 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
1777 |
$47.82 |
$84.98K |
Restricted Stock Units |
Exercise/Conversion
|
3958 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
3780 |
$0.00 |
$- |
|
February 26th, 2025 |
Sarah Condella |
Evp, Human Resources |
Stock Award Payment In Kind Exercise
|
33.58K |
$95.33K |
80.30K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
3954 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
1859 |
$51.28 |
$95.33K |
Restricted Stock Units |
Stock Award
|
23817 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
3954 |
$0.00 |
$- |
|
February 26th, 2025 |
Brian Baranick |
Evp, Gm, Precision Oncology |
Stock Award Payment In Kind Exercise
|
38.70K |
$102.97K |
28.78K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Restricted Stock Units |
Stock Award
|
28779 |
$0.00 |
$- |
Common Stock |
Exercise/Conversion
|
3954 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
2008 |
$51.28 |
$102.97K |
Restricted Stock Units |
Exercise/Conversion
|
3954 |
$0.00 |
$- |
|
February 26th, 2025 |
James Herriott |
Svp, General Counsel & Sec |
Stock Award Payment In Kind Exercise
|
17.96K |
$39.74K |
13.89K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Restricted Stock Units |
Stock Award
|
13893 |
$0.00 |
$- |
Common Stock |
Exercise/Conversion
|
1647 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
775 |
$51.28 |
$39.74K |
Restricted Stock Units |
Exercise/Conversion
|
1647 |
$0.00 |
$- |
|
February 26th, 2025 |
Jacob Orville |
Evp, Gm, Screening |
Stock Award Payment In Kind Exercise
|
38.55K |
$95.33K |
28.78K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Restricted Stock Units |
Stock Award
|
28779 |
$0.00 |
$- |
Common Stock |
Exercise/Conversion
|
3954 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
1859 |
$51.28 |
$95.33K |
Restricted Stock Units |
Exercise/Conversion
|
3954 |
$0.00 |
$- |
|
February 26th, 2025 |
Aaron Bloomer |
Evp, Chief Financial Officer |
Stock Award
|
28.78K |
$- |
28.78K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Restricted Stock Units |
Stock Award
|
28779 |
$0.00 |
$- |
|
February 26th, 2025 |
Kevin Conroy |
Director, Officer: President And CEO |
Stock Award Payment In Kind Exercise
|
143.70K |
$317.68K |
1.12M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
13180 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
6195 |
$51.28 |
$317.68K |
Restricted Stock Units |
Stock Award
|
111146 |
$0.00 |
$- |
Restricted Stock Units |
Exercise/Conversion
|
13180 |
$0.00 |
$- |
|
February 21st, 2025 |
Kevin Conroy |
Director, Officer: President And CEO |
Stock Award Payment In Kind Exercise
|
93.20K |
$1.23M |
1.13M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
48044 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
21140 |
$50.48 |
$1.07M |
Common Stock |
Exercise/Conversion
|
10374 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
3271 |
$49.63 |
$162.34K |
Restricted Stock Units |
Exercise/Conversion
|
10374 |
$0.00 |
$- |
|
February 21st, 2025 |
D Coward |
Director |
Payment In Kind Exercise
|
5.16K |
$33.10K |
52.83K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
2248 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
667 |
$49.63 |
$33.10K |
Restricted Stock Units |
Exercise/Conversion
|
2248 |
$0.00 |
$- |
|
February 21st, 2025 |
Jacob Orville |
Evp, Gm, Screening |
Stock Award Payment In Kind Exercise
|
12.61K |
$166.22K |
20.41K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
4805 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
2225 |
$50.48 |
$112.32K |
Common Stock |
Exercise/Conversion
|
2248 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
1086 |
$49.63 |
$53.90K |
Restricted Stock Units |
Exercise/Conversion
|
2248 |
$0.00 |
$- |
|
February 21st, 2025 |
Brian Baranick |
Evp, Gm, Precision Oncology |
Stock Award Payment In Kind Exercise
|
11.67K |
$171.06K |
18.32K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
4805 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
2437 |
$50.48 |
$123.02K |
Common Stock |
Exercise/Conversion
|
1729 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
968 |
$49.63 |
$48.04K |
Restricted Stock Units |
Exercise/Conversion
|
1729 |
$0.00 |
$- |
|
February 21st, 2025 |
Sarah Condella |
Evp, Human Resources |
Stock Award Payment In Kind Exercise
|
12.62K |
$166.70K |
78.56K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
4805 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
2214 |
$50.48 |
$111.76K |
Common Stock |
Exercise/Conversion
|
2248 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
1107 |
$49.63 |
$54.94K |
Restricted Stock Units |
Exercise/Conversion
|
2248 |
$0.00 |
$- |
|
February 21st, 2025 |
James Herriott |
Svp, General Counsel & Sec |
Stock Award Payment In Kind Exercise
|
7.02K |
$98.77K |
13.62K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
3324 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
1531 |
$50.48 |
$77.28K |
Common Stock |
Exercise/Conversion
|
865 |
$0.00 |
$- |
Common Stock |
Payment In Kind
|
433 |
$49.63 |
$21.49K |
Restricted Stock Units |
Exercise/Conversion
|
865 |
$0.00 |
$- |
|
January 6th, 2025 |
Kimberly Popovits |
Director |
Stock Award
|
6.39K |
$- |
6.39K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
6387 |
$0.00 |
$- |
|
January 6th, 2025 |
Kimberly Popovits |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
December 20th, 2024 |
Katherine Zanotti |
Director |
Stock Award
|
5.94K |
$- |
70.57K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5939 |
$0.00 |
$- |
|
December 20th, 2024 |
Daniel Levangie |
Director |
Stock Award
|
5.94K |
$- |
28.91K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5939 |
$0.00 |
$- |
|
December 20th, 2024 |
Shacey Petrovic |
Director |
Stock Award
|
5.94K |
$- |
16.41K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5939 |
$0.00 |
$- |
|
December 20th, 2024 |
Michael Barber |
Director |
Stock Award
|
5.94K |
$- |
5.94K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5939 |
$0.00 |
$- |
|
December 20th, 2024 |
James Doyle |
Director |
Stock Award
|
5.94K |
$- |
56.05K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5939 |
$0.00 |
$- |
|
December 20th, 2024 |
Paul Clancy |
Director |
Stock Award
|
5.94K |
$- |
20.64K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5939 |
$0.00 |
$- |
|
December 20th, 2024 |
D Coward |
Director |
Stock Award
|
5.94K |
$- |
50.58K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
5939 |
$0.00 |
$- |
|
December 20th, 2024 |
Kathleen Sebelius |
Director |
Stock Award
|
7.67K |
$- |
32.67K |
Form 4/A
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
7672 |
$0.00 |
$- |
|
November 13th, 2024 |
Kevin Conroy |
Director, Officer: President And CEO |
Purchase
|
19.50K |
$1.00M |
1.07M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
19500 |
$51.35 |
$1.00M |
|